High-dose radiation plus long-term ADT extended survival in prostate cancer

Men with intermediate or high-risk prostate cancer who underwent high-dose radiation therapy followed by a longer duration of androgen deprivation therapy demonstrated longer OS than those who underwent high-dose radiation followed by short-term androgen deprivation therapy, according to results of a randomized phase 3 trial presented at the ASTRO Annual Meeting.